Ondansentron and dexamethasone treatment with different dosing schedules (24 versus 32 mg) in patients with non-small-cell lung cancer under cisplatin-based chemotherapy: a randomized study.

Source:http://linkedlifedata.com/resource/pubmed/id/10965102

Download in:

View as

General Info

PMID
10965102